HLA-DRB3 (gene)

From Wikipedia, the free encyclopedia

Major histocompatibility complex, class II, DR beta 3

PDB rendering based on 1a6a.

Available structures: 1a6a, 1d5m, 1d5x, 1d5z, 1d6e, 1j8h, 2seb

Identifiers

HLA-DRB3; HLA-DR3B; MGC117330

Gene ontology
Molecular Function:	• MHC class II receptor activity
Cellular Component:	• integral to plasma membrane • membrane • integral to membrane • MHC class II protein complex
Biological Process:	• antigen processing and presentation of peptide or polysaccharide antigen via MHC class II • immune response • signal transduction

RNA expression pattern

More reference expression data

Orthologs

Human

Mouse

n/a

n/a

n/a

Refseq

NM_022555 (mRNA)
NP_072049 (protein)

n/a (mRNA)
n/a (protein)

Location

Chr c6_COX: 32.56 - 32.57 Mb

n/a

Pubmed search

[1]

n/a

Major histocompatibility complex, class II, DR beta 3, also known as HLA-DRB3, is a human gene.^[1]

HLA-DRB3 belongs to the HLA class II beta chain paralogues. This class II molecule is a heterodimer consisting of an alpha (DRA) and a beta (DRB) chain, both anchored in the membrane. It plays a central role in the immune system by presenting peptides derived from extracellular proteins. Class II molecules are expressed in antigen presenting cells (APC: B lymphocytes, dendritic cells, macrophages). The beta chain is approximately 26-28 kDa and its gene contains 6 exons. Exon one encodes the leader peptide, exons 2 and 3 encode the two extracellular domains, exon 4 encodes the transmembrane domain and exon 5 encodes the cytoplasmic tail. Within the DR molecule the beta chain contains all the polymorphisms specifying the peptide binding specificities. Typing for these polymorphisms is routinely done for bone marrow and kidney transplantation. DRB1 is expressed at a level five times higher than its paralogues DRB3, DRB4 and DRB5. The presence of DRB3 is linked with allelic variants of DRB1, otherwise it is omitted. There are 4 related pseudogenes: DRB2, DRB6, DRB7, DRB8 and DRB9.^[1]

[edit] References

^ ^a ^b Entrez Gene: HLA-DRB3 major histocompatibility complex, class II, DR beta 3.

[edit] Further reading

Germain RN (1996). "Binding domain regulation of MHC class II molecule assembly, trafficking, fate, and function.". Semin. Immunol. 7 (6): 361-72. doi:10.1006/smim.1995.0041. PMID 8775462.
Piatier-Tonneau D, Gastinel LN, Amblard F, et al. (1991). "Interaction of CD4 with HLA class II antigens and HIV gp120.". Immunogenetics 34 (2): 121-8. PMID 1869305.
Nong Y, Kandil O, Tobin EH, et al. (1991). "The HIV core protein p24 inhibits interferon-gamma-induced increase of HLA-DR and cytochrome b heavy chain mRNA levels in the human monocyte-like cell line THP1.". Cell. Immunol. 132 (1): 10-6. PMID 1905983.
Ress SR, Rousseau J, Ratanjee B, et al. (1991). "HLA class II induction by interferon-gamma in K562 variant cell line: inhibition by serum lipid.". Hum. Immunol. 31 (1): 57-66. PMID 1908841.
Rosenstein Y, Burakoff SJ, Herrmann SH (1990). "HIV-gp120 can block CD4-class II MHC-mediated adhesion.". J. Immunol. 144 (2): 526-31. PMID 1967269.
Callahan KM, Fort MM, Obah EA, et al. (1990). "Genetic variability in HIV-1 gp120 affects interactions with HLA molecules and T cell receptor.". J. Immunol. 144 (9): 3341-6. PMID 1970352.
Bowman MR, MacFerrin KD, Schreiber SL, Burakoff SJ (1991). "Identification and structural analysis of residues in the V1 region of CD4 involved in interaction with human immunodeficiency virus envelope glycoprotein gp120 and class II major histocompatibility complex molecules.". Proc. Natl. Acad. Sci. U.S.A. 87 (22): 9052-6. PMID 1978941.
Gorski J (1989). "HLA-DR beta-chain polymorphism. Second domain polymorphism reflects evolutionary relatedness of alleles and may explain public serologic epitopes.". J. Immunol. 143 (1): 329-33. PMID 2471740.
Kao HT, Gregersen PK, Tang JC, et al. (1989). "Molecular analysis of the HLA class II genes in two DRw6-related haplotypes, DRw13 DQw1 and DRw14 DQw3.". J. Immunol. 142 (5): 1743-7. PMID 2493052.
Jonsson AK, Andersson L, Rask L (1989). "A cellular and functional split in the DRw8 haplotype is due to a single amino acid replacement (DR beta ser 57- asp 57).". Immunogenetics 29 (5): 308-16. PMID 2497068.
Clayton LK, Sieh M, Pious DA, Reinherz EL (1989). "Identification of human CD4 residues affecting class II MHC versus HIV-1 gp120 binding.". Nature 339 (6225): 548-51. doi:10.1038/339548a0. PMID 2543930.
Diamond DC, Sleckman BP, Gregory T, et al. (1988). "Inhibition of CD4+ T cell function by the HIV envelope protein, gp120.". J. Immunol. 141 (11): 3715-7. PMID 2846691.
Angelini G, de Preval C, Gorski J, Mach B (1986). "High-resolution analysis of the human HLA-DR polymorphism by hybridization with sequence-specific oligonucleotide probes.". Proc. Natl. Acad. Sci. U.S.A. 83 (12): 4489-93. PMID 3012569.
Didier DK, Schiffenbauer J, Shuman S, et al. (1986). "Characterization of two distinct DR beta chain alleles at the beta III locus of the DR5 haplotype: beta III alleles are highly conserved.". J. Immunol. 137 (8): 2627-31. PMID 3020126.
Young JA, Wilkinson D, Bodmer WF, Trowsdale J (1987). "Sequence and evolution of HLA-DR7- and -DRw53-associated beta-chain genes.". Proc. Natl. Acad. Sci. U.S.A. 84 (14): 4929-33. PMID 3110774.
Horn GT, Bugawan TL, Long CM, et al. (1988). "Sequence analysis of HLA class II genes from insulin-dependent diabetic individuals.". Hum. Immunol. 21 (4): 249-63. PMID 3372263.
Gorski J, Mach B (1986). "Polymorphism of human Ia antigens: gene conversion between two DR beta loci results in a new HLA-D/DR specificity.". Nature 322 (6074): 67-70. doi:10.1038/322067a0. PMID 3459965.
Gregersen PK, Moriuchi T, Karr RW, et al. (1987). "Polymorphism of HLA-DR beta chains in DR4, -7, and -9 haplotypes: implications for the mechanisms of allelic variation.". Proc. Natl. Acad. Sci. U.S.A. 83 (23): 9149-53. PMID 3466180.
Bell JI, Denney D, Foster L, et al. (1987). "Allelic variation in the DR subregion of the human major histocompatibility complex.". Proc. Natl. Acad. Sci. U.S.A. 84 (17): 6234-8. PMID 3476943.
Andrieu JM, Even P, Venet A (1986). "AIDS and related syndromes as a viral-induced autoimmune disease of the immune system: an anti-MHC II disorder. Therapeutic implications.". AIDS research 2 (3): 163-74. PMID 3489470.